COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies.
Andreoli L, Sen P, Lini D, Vincze MN, Schreiber K, Agarwal V, Aggarwal R, Gupta L (2023)
Publication Type: Journal article
Publication year: 2023
Journal
Book Volume: 62
Pages Range: e175-e179
Journal Issue: 6
DOI: 10.1093/rheumatology/keac644
Involved external institutions
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Italy (IT)
IRS Danish Hospital for Rheumatic Diseases
Denmark (DK)
Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS)
India (IN)
University of Pittsburgh
United States (USA) (US)
Maulana Azad Medical College (MAMC)
India (IN)
University of Debrecen / Debreceni Egyetem
Hungary (HU)
Italy (IT)
IRS Danish Hospital for Rheumatic Diseases
Denmark (DK)
Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS)
India (IN)
University of Pittsburgh
United States (USA) (US)
Maulana Azad Medical College (MAMC)
India (IN)
University of Debrecen / Debreceni Egyetem
Hungary (HU)
How to cite
APA:
Andreoli, L., Sen, P., Lini, D., Vincze, M.N., Schreiber, K., Agarwal, V.,... Gupta, L. (2023). COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies. Rheumatology, 62(6), e175-e179. https://doi.org/10.1093/rheumatology/keac644
MLA:
Andreoli, Laura, et al. "COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies." Rheumatology 62.6 (2023): e175-e179.
BibTeX: Download